Caracteristicas cognitivas y oculares en enfermedad de Alzheimer

dc.creatorGarzón P, Sandra Johanna
dc.creatorCamacho M, Marcela
dc.creatorTapiero L., Jessica Andrea
dc.creatorReina, Karen Daniela
dc.date.accessioned2019-11-08T21:25:05Z
dc.date.accessioned2022-09-28T12:35:07Z
dc.date.available2019-11-08T21:25:05Z
dc.date.available2022-09-28T12:35:07Z
dc.date.created2019-11-08T21:25:05Z
dc.identifierhttps://repository.unad.edu.co/handle/10596/30054
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3634580
dc.publisherUniversidad Colegio Mayor de Cundinamarca
dc.relationhttp://hemeroteca.unad.edu.co/index.php/nova/article/view/2693/2797
dc.relation/*ref*/Patrick E, Rajagopal S, Wong H-KA, McCabe C, Xu J, Tang A, et al. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease. Mol Neurodegener [Internet]. 2017;12(1):51. Available from: http://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-017-0191-y
dc.relation/*ref*/Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol [Internet]. 2014;71(11):1394–404. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25199842%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4314944
dc.relation/*ref*/Reitz C, Mayeux R. Alzheimer disease: Epidemiology, Diagnostic Criteria, Rist Factors and Biomarkers. Biochem Pharmacol. 2014;88(4):640–51.
dc.relation/*ref*/Javaid FZ, Brenton J, Guo L, Cordeiro MF. Visual and ocular manifestations of Alzheimer’s disease and their use as biomarkers for diagnosis and progression. Front Neurol. 2016;7(APR).
dc.relation/*ref*/Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M. Ocular indicators of Alzheimer’s: exploring disease in the retina. Acta Neuropathol [Internet]. 2016;132(6):767–87. Available from: https://doi.org/10.1007/s00401-016-1613-6
dc.relation/*ref*/Lang A, Carass A, Al-Louzi O, Bhargava P, Solomon SD, Calabresi PA, et al. Combined registration and motion correction of longitudinal retinal OCT data. 2016;97840X. Available from: http://proceedings.spiedigitallibrary.org/proceeding.aspx?doi=10.1117/12.2217157
dc.relation/*ref*/Haaksma ML, Vilela LR, Marengoni A, Caldero A, Leoutsakos JS, Rikkert MGMO. Comorbidity and progression of late onset Alzheimer ’ s disease : A systematic review. 2017;(May):1–15.
dc.relation/*ref*/Lopera F. La enfermedad de Alzheimer familiar. Desde la Bibl [Internet]. 2016;0(51):63–73. Available from: http://itmojs. itm.edu.co/index.php/desdelabiblioteca/article/view/915
dc.relation/*ref*/Chao, MD, MSc*, J. Scott Roberts, PhD†, Theresa M. Marteau, PhD‡, Rebecca Silliman, MD, PhD*,§, L. Adrienne Cupples, PhD‡, and Robert C. Green, MD M. Health Behavior Changes After Genetic Risk Assessment for Alzheimer Disease: The REVEAL Study. Alzheimer Dis Assoc Disord. 2008;100(2):130–4.
dc.relation/*ref*/Vega GL, Weiner MF, Lipton AM, Von Bergmann K, Lutjohann D, Moore C, et al. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurol [Internet]. 2003;60(4):510–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12707064
dc.relation/*ref*/Leoni V. Oxysterols as markers of neurological disease - A review. Scand J Clin Lab Invest. 2009;69(1):22–5.
dc.relation/*ref*/Pawlowski M, Meuth SG, Duning T. Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside. Diagnostics [Internet]. 2017;7(3):42. Available from: http://www.mdpi.com/2075-4418/7/3/42
dc.relation/*ref*/Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283(44):29615–9.
dc.relation/*ref*/Tabaton M, Piccini A. Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer’s disease. Int J Exp Pathol [Internet]. 2005;86(3):139–45. Available from: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=2517412&-tool=pmcentrez&rendertype=abstract
dc.relation/*ref*/Herrera-Rivero M, Hernández-Aguilar ME, Manzo J, Aranda- Abreu GE. Alzheimer â€TM s disease : Immunity and diagnosis Enfermedad de Alzheimer : inmunidad y diagnóstico. Rev Neurol. 2016;(November).
dc.relation/*ref*/Chiasseu M, Alarcon-Martinez L, Belforte N, Quintero H, Dotigny F, Destroismaisons L, et al. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer’s disease. Mol Neurodegener [Internet]. 2017;12(1):58. Available from: http://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-017-0199-3
dc.relation/*ref*/Custodio N, Montesinos R, Alva C, Mejía K, Becerra Y, Lira D. Nuevos términos clínicos , prevención y tratamiento del trastorno cognitivo vascular : revisión de literatura basada en la evidencia. Rev Neuropsiquiatr [Internet]. 2016;79(3):152–65. Available from: http://www.scielo.org.pe/pdf/rnp/v79n3/a04v79n3.pdf
dc.relation/*ref*/Minsalud. Informe al Congreso de la República 2014-2015. Minist Salud y Protección Soc [Internet]. 2015;194. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/PES/informe-congreso-2014-2015.pdf
dc.relation/*ref*/Armstrong R a. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease. Folia Neuropathol. 2009;47(4):289–99.
dc.relation/*ref*/Sánchez CR De, Nariño D, Fernando J, Cerón M. Epidemiología y carga de la Enfermedad de Alzheimer. Acta Neurológica Colomb. 2010;26(3):87–94.
dc.relation/*ref*/Hurtado AMA, Quintana ASSR. Relación entre la calidad de vida en salud y la carga física en uidadores de personas con enfermedad de Alzheimer. Rev Colomb Salud Ocup. 2016;6(1):18–23.
dc.relation/*ref*/Carvajal-castrillón J, Marina L, Toro G, Estrada DO, Ramírez AA, Peláez AR, et al. Prevalencia de síndromes neuropsicológicos del adulto en una unidad de neuropsicología en Medellín , Colombia Prevalence of adult neuropsychological syndromes in a neuropsychology unit. Acta Neurológica Colomb.2015;31(1):20–6.
dc.relation/*ref*/Batsch NL, Mittelman MS. Overcoming the stigma of dementia, World Alzheimer Report 2012 [Internet]. Www.Alz. Co.Uk. 2012. 1-80 p. Available from: papers2://publication/uuid/889ADA69-3B6E-4DCC-BF40-936650E90072
dc.relation/*ref*/Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease. N Engl J Med [Internet]. 2012;367(9):795–804. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1202753
dc.relation/*ref*/Crous-Bou M, Minguillón C, Gramunt N, Molinuevo JL. Alzheimer’s disease prevention: from risk factors to early intervention.Alzheimers Res Ther [Internet]. 2017;9(1):71. Available from: http://alzres.biomedcentral.com/articles/10.1186/s13195-017-0297-z
dc.relation/*ref*/Ji F, Pasternak O, Liu S, Loke YM, Choo BL, Hilal S, et al. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer’s disease with and without cerebrovascular disease. Alzheimers Res Ther [Internet]. 2017;9(1):63. Available from: http://alzres.biomedcentral.com/articles/10.1186/s13195-017-0292-4
dc.relation/*ref*/Croteau E, Castellano CA, Fortier M, Bocti C, Fulop T, Paquet N, et al. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer’s disease. Exp Gerontol [Internet]. 2017; Available from: http://linkinghub.elsevier.com/retrieve/pii/S0531556517302280
dc.relation/*ref*/Epperly T, Dunay MA, Boice JL. Alzheimer Disease: Pharmacologic and Nonpharmacologic Therapies for Cognitive and Functional Symptoms. Am Fam Physician. 2017;95(12):771–8.
dc.relation/*ref*/Tam WK, Chan H, Brown B, Leung KW, Woo V, Yap M. Aging and mfERG topography. Eye. 2006;20(1):18–24.
dc.relation/*ref*/Hollands C, Tobin MK, Hsu M, Musaraca K, Yu T-S, Mishra R, et al. Depletion of adult neurogenesis exacerbates cognitive deficits in Alzheimer’s disease by compromising hippocampal inhibition. Mol Neurodegener [Internet]. 2017;12(1):64. Available from: http://molecularneurodegeneration. biomedcentral.com/articles/10.1186/s13024-017-0207-7
dc.relation/*ref*/Chan D, Gallaher LM, Moodley K, Minati L, Burgess N, Hartley T. The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer’s Disease. J Vis Exp [Internet]. 2016;(116). Available from: http://www.jove.com/video/54454/the-4-mountains-test-short-test-spatial-memory-with-high-sensitivity
dc.relation/*ref*/Bruni BM, Granado FB, Prado RA. Avaliação do equilíbrio postural em idosos praticantes de hidroterapia em grupo. O Mundo da Saúde. 2008;32(1):56–63.
dc.relation/*ref*/Mar J, Soto-Gordoa M, Arrospide A, Moreno-Izco F, Martínez-Lage P. Fitting the epidemiology and neuropathology of the early stages of Alzheimer’s disease to prevent dementia.Alzheimers Res Ther [Internet]. 2015;7(1):2. Available from: http://alzres.com/content/7/1/2
dc.relation/*ref*/EC M, KV P. Cognitive decline in preclinical stage 2 alzheimer disease and implications for prevention trials. JAMA Neurol [Internet]. 2016 Jun 1;73(6):640–2. Available from: http://dx.doi.org/10.1001/jamaneurol.2016.0281
dc.relation/*ref*/TRABAJO FIN DE GRADO TÍTULO : “ BIOMARCADORES EN LA ENFERMEDAD DE ALZHEIMER .”2016 :1–22.
dc.relation/*ref*/Ma D, Alonso E, Ana D, Sosa L, Sotelo J, Ausman J, et al. Visión actual de las demencias. Arch Neurociencias.2016;21(Suplemento Especial):1–8.
dc.relation/*ref*/Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis. Alzheimer’s Dement Diagnosis, Assess Dis Monit [Internet]. 2017;6:108–21. Available from: http://dx.doi. org/10.1016/j.dadm.2016.09.002
dc.relation/*ref*/TL K, Goldacre R, MJ G. Associations between age-related macular degeneration, alzheimer disease, and dementia: Record linkage study of hospital admissions. JAMA Ophthalmol [Internet]. 2014 Jan 1;132(1):63–8. Available from: http://dx.doi.org/10.1001/jamaophthalmol.2013.5696
dc.relation/*ref*/Williams MA, McGowan AJ, Cardwell CR, Cheung CY, Craig D, Passmore P, et al. Retinal microvascular network attenuation in Alzheimer’s disease. Alzheimer’s Dement Diagnosis, Assess Dis Monit [Internet]. 2015;1(2):229–35. Available from: http://dx.doi.org/10.1016/j.dadm.2015.04.001
dc.relation/*ref*/Schwitzer T, Schwan R, Bubl E, Lalanne L, Angioi-Duprez K, Laprevote V. Looking into the brain through the retinal ganglion cells in psychiatric disorders: A review of evidences. Prog Neuro-Psychopharmacology Biol Psychiatry [Internet]. 2017;76(January):155–62. Available from: http://dx.doi.org/10.1016/j.pnpbp.2017.03.008
dc.relation/*ref*/den Haan J, Verbraak FD, Visser PJ, Bouwman FH. Retinal thickness in Alzheimer’s disease: A systematic review and meta-analysis. Alzheimer’s Dement Diagnosis, Assess Dis Monit[Internet]. 2017;6:162–70. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2352872916300793
dc.relation/*ref*/Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, et al. Retinal Nerve Fiber Layer Thinning in Alzheimer’s Disease. Am J Alzheimer’s Dis Other Dementiasr [Internet]. 2016;31(5):430–6. Available from: http://journals.sagepub.com/doi/10.1177/1533317515628053
dc.relation/*ref*/Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G, et al. Optical coherence tomography in Alzhei mer’s disease: A meta-analysis. PLoS One. 2015;10(8):1–14.
dc.relation/*ref*/Ong YT, Hilal S, Cheung CY, Venketasubramanian N, Niessen WJ, Vrooman H, et al. Retinal neurodegeneration on optical coherence tomography and cerebral atrophy. Neurosci Lett. 2015;584:12–6.
dc.relation/*ref*/Khawaja AP, Chan MPY, Yip JLY, Broadway DC, Garway-Heath DF, Luben R, et al. Retinal Nerve Fiber Layer Measures and Cognitive Function in the EPIC-Norfolk Cohort Study. Investig Opthalmology Vis Sci [Internet]. 2016;57(4):1921.Available from: http://iovs.arvojournals.org/article.aspx?-doi=10.1167/iovs.16-19067
dc.relation/*ref*/La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, et al. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol. 2016;79(1):90–109.
dc.relation/*ref*/Pavisic IM, Firth NC, Parsons S, Rego DM, Shakespeare TJ, Yong KXX, et al. Eyetracking metrics in young onset alzheimer’s disease: A Window into cognitive visual functions. Front Neurol. 2017;8(AUG):1–16.
dc.relation/*ref*/Kirby E, Bandelow S, Hogervorst E. Visual Impairment in Alzheimer’s Disease: A Critical Review. Vol. 21, Journal of Alzheimer’s disease : JAD. 2010. 15-34 p.
dc.relation/*ref*/Pal S, Sanyal D, Biswas A, Paul N, Das SK. Visual Manifestations in Alzheimer’s disease: A Clinic-Based Study From India. Am J Alzheimer’s Dis Other Dementiasr [Internet]. 2013 Jul 2;28(6):575–82. Available from: https://doi.org/10.1177/1533317513494448
dc.relation/*ref*/García EP, Echevarría IOH, Rodríguez IY. Obtención , interpretación y usos del electrorretinograma multifocal Obtaining , interpreting and using the multifocal electroretinogram.2016;29(1):105–23.
dc.relation/*ref*/Bernal Luz Mery, López Greizy. Diagnóstico prénatal: retrospectiva. Nova. 2014; 12( 21 ): 23-36.
dc.relation/*ref*/Márquez Gómez Marco Antonio, Gómez Díaz Graciela María. Accidente ofídico en el departamento de Sucre, Colombia.Nova. 2015; 13( 24 ): 39-46.
dc.relation/*ref*/González Yuri Lilian. Evaluación de la percepción del riesgo ocupacional en trabajadores de una empresa del sector de la construcción en Bogotá D.C. Nova. 2015; 13( 23 ): 93-107.
dc.relation/*ref*/Naranjo Flórez Ricardo Andrés. Avances y perspectivas en Síndrome de Asperger. Nova. 2014; 12( 21 ): 81-101.
dc.relation/*ref*/Almonacid Urrego Carmen Cecilia, Camarillo Romero María del Socorro, Gil Murcia Zulay, Medina Medina Claudia Yasmin, Rebellón Marulanda Jennifer Viviana, Mendieta Zerón Hugo. Evaluación de factores de riesgo asociados a enfermedad cardiovascular en jóvenes universitarios de la Localidad Santafé en Bogotá, Colombia. Nova. 2016; 14(25): 9-17.
dc.relation/*ref*/González Devia Johanna L., Monroy Romero Paola A., Almonacid Urrego Carmen C.. Homocisteína y otros factores de riesgo cardiovascular en niños de educación básica primaria del Colegio Distrital Manuel Elkin Patarroyo, Bogotá, D.C. Colombia. Estudio piloto. Nova. 2017 ; 15( 27 ): 103-117.
dc.relation/*ref*/Armstrong RA, Syed AB. Alzheimer’s disease and the eye. Ophthalmic Physiol Opt [Internet]. 2009;16(SUPPL. 1):103–11. Available from: http://dx.doi.org/10.3921/joptom. 2009.103
dc.relation/*ref*/Sivak, J. The Aging Eye: Common Degenerative Mechanisms Between the Alzheimer’s Brain and Retinal Disease. Investigative Ophthalmology & Visual Science. [Internet] 2013, Vol. 54, No. 1. Available from: doi:10.1167/iovs.12-10827
dc.rightsCopyright (c) 2018 Nova
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0
dc.sourceNOVA Biomedical Sciences Journal; Vol. 16, Núm. 29 (2018); 101 - 114
dc.sourceNova; Vol. 16, Núm. 29 (2018); 101 - 114
dc.sourceNOVA Ciências Biomédicas Publicação; Vol. 16, Núm. 29 (2018); 101 - 114
dc.source2462-9448
dc.source1794-2470
dc.subjectEnfermedad de Alzheimer; alteración cognitiva visual en Alzheimer; retina y Alzheimer.
dc.titleCaracteristicas cognitivas y oculares en enfermedad de Alzheimer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typereviewArticle
dc.typereviewArticle
dc.typereviewArticle


Este ítem pertenece a la siguiente institución